Veru Inc. Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

37.72M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	-	-	-
Sep 30, 2024	-	-	-
Sep 30, 2023	16.30M	-23.06M	-58.59%
Sep 30, 2022	39.35M	-21.91M	-35.76%
Sep 30, 2021	61.26M	18.67M	43.83%
Sep 30, 2020	42.59M	10.79M	33.92%
Sep 30, 2019	31.80M	15.94M	100.47%
Sep 30, 2018	15.86M	2.21M	16.18%
Sep 30, 2017	13.66M	-8.47M	-38.29%
Sep 30, 2016	22.13M	-10.48M	-32.14%
Sep 30, 2015	32.60M	8.11M	33.13%
Sep 30, 2014	24.49M	-6.97M	-22.15%
Sep 30, 2013	31.46M	-3.58M	-10.21%
Sep 30, 2012	35.03M	16.47M	88.71%
Sep 30, 2011	18.57M	-3.66M	-16.46%
Sep 30, 2010	22.22M	-5.32M	-19.32%
Sep 30, 2009	27.54M	1.91M	7.45%
Sep 30, 2008	25.63M	6.31M	32.68%
Sep 30, 2007	19.32M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Evaxion	7.53M
Aligos Therapeutics	4.71M
Daré Bioscience	1.16M
Outlook Therapeutics	333.14K
Actinium Pharmaceuticals	90.00K
INmune Bio	50.00K

Revenue Rankings

VERU News

8 days ago - Veru price target lowered to $24 from $25 at Oppenheimer - TheFly
10 days ago - Veru Inc. Earnings Call Transcript: Q2 2026 - Transcripts
10 days ago - Veru Inc. Earnings release: Q2 2026 - Filings
10 days ago - Veru Inc. Quarterly report: Q2 2026 - Filings
10 days ago - Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress - GlobeNewsWire
17 days ago - Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th - GlobeNewsWire
6 weeks ago - Veru files $200M mixed securities shelf - TheFly
6 weeks ago - Veru files to sell 23.8M shares of common stock - TheFly

More News